Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Orbia
United States
- Boston
- 28/11/2022
- Series B
- $10,000,000
Orbia is a company driven by a shared purpose: to advance life around the world. Orbia operates in the Polymer Solutions (Vestolit and Alphagary), Building and Infrastructure (Wavin), Precision Agriculture (Netafim), Data Communications (Dura-Line) and Fluorinated Solutions (Koura) sectors, with a collective focus on expanding access to health and wellness, reinventing the future of cities and homes, ensuring food and water security, connecting communities to data infrastructure and accelerating a sustainable, circular economy with basic and advanced materials and solutions.
- Industry Utilities
- Website https://www.orbia.com/
- LinkedIn https://www.linkedin.com/company/orbiaglobal/
Related People
Eitan DekelInvestor
United States -
Graton, California
An experienced Venture capitalist and corporate development executive,
Superior verbal and in-person communication skills, Strong analytical and technical background
Experience in strategy, product ,business development and financing.
Experience and track record in analyzing and identifying new technology trends and business models .
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)